Degradation of specific polyunsaturated fatty acids in red blood cells stored at -20°C proceeds faster in patients with schizophrenia when compared with healthy controls

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 69, Issue 5, 2003, Pages 291-297

  Fox, Helen ^a   Ross, Brian M ^b   Tocher, Douglas ^c   Horrobin, David ^d   Glen, Iain ^b   St Clair, David ^a  

^a ROYAL CORNHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF THE HIGHLANDS AND ISLANDS   (United Kingdom)

^c UNIVERSITY OF STIRLING   (United Kingdom)

^d Laxdale Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID;

ADULT; ARTICLE; BLOOD STORAGE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ERYTHROCYTE PRESERVATION; FATTY ACID METABOLISM; FEMALE; FREEZING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; OXIDATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHIZOPHRENIA; STORAGE TEMPERATURE; STUDENT T TEST;

EID: 0242351790     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(03)00084-X     Document Type: Article

References (23)

1. D.F. Horrobin, A.I. Glen, K. Vaddadi, The membrane hypothesis of schizophrenia, Schizophr. Res. 13 (1994) 195-207.
2. N. Walker, H. Fox, L. Whalley, Lipids and schizophrenia: A review, Br. J. Psychiatry 174 (1999) 101-104.
3. J.K. Yao, D.P. van Kammen, J.A Welker, Red blood cell membrane dynamics in schizophrenia 11 Fatty acid composition. Schizophr. Res. 13 (1994) 217-226.
4. A.I. Glen, E.M. Glen, D.F. Horrobin, et al., A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases, Schizophr. Res. 12 (1994) 53-61.
5. M. Peet, J. Laugharne, N. Rangarajan, D. Horrobin, G. Reynolds, Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients, J. Psychiatr. Res. 29 (1995) 227-232.
6. K.S. Vaddadi, C.J. Gilleard, E. Soosai, A. Polonowita, R. Gibson, G. Burrows, Schizophrenia, tardive dyskinesia and essential fatty acid, Schizophr. Res. 20 (1996) 287-294.
7. A.B. Doris, K. Wahle, A. MacDonald, et al., Red blood cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia, Schizophr. Res. 31 (1998) 185-196.
8. J. Assies, R. Lieverse, P. Vreken, R. Wanders, P. Dingemans, D. Linszen, Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group, Biol. Psychiatry 49 (2001) 510-522.
9. V.L. Brown, J.C. Shay, L. Morse N, et al., Effect of repeated periods of freezing and thawing on fatty acid composition of red blood cells and plasma, Med. Sci. Res. 20 (1992) 225-227.
10. L. Di Marino, A. Maffettone, P. Cipriano, et al., Assay of erythrocyte membrane fatty acids. Effects of storage time at low temperature, Int. J. Clin. Lab. Res. 30 (2000) 197-202.
11. P. McGuffin, A. Farmer, I. Harvey, Apolydiagnostic application of operational criteria in studies of psychotic illness - development and reliability of the OPCRIT system, Arch. Gen. Psychiatry 48 (8) (1991) 764-770.
12. W.W. Christie (Eds.), Lipid Analysis, 2nd Edition, Pergamon Press, Oxford, 1982.
13. M.V. Bell, D.R. Tocher, Molecular species composition of the major phospholipids in brain and retina from rainbow trout, Biochem. J. 264 (1989) 909-915.
14. R. Wilson, D.R. Tocher, Lipid and fatty acid composition is altered in plaque tissue from multiple sclerosis brain compared with normal brain white matter, Lipids 26 (1999) 9-15.
15. R. McCreadie, E. MacDonald, D. Wiles, G. Campbell, J. Paterson, The nithsdale schizophrenia surveys. XIV: plasma lipid peroxide and serum vitamin e levels in patients with and without tardive dyskinesia, and in normal subjects, Br. J. Psychiatry 167 (1995) 610-617.
16. 2 activity in schizophrenia: a replication study, Biol. Psychiatry 28 (1990) 495-501.
17. 2 associated with schizophrenia, Schizophr. Res. 21 (1996) 111-116.
18. 2 gene, Psychiatr. Genet. 7 (3) (1997) 111-114.
19. 2 activity in rat lung and liver, J. Nutr. 125 (1995) 1419-1429.
20. 2, FEBS Lett. 509 (2001) 399-404.
21. R. McCreadie, Smoking habits and plasma lipid peroxide and vitamin E levels in never-treated first-episode patients with schizophrenia, Br. J. Psychiatry 176 (2000) 290-293.
22. 2 in the lower respiratory tract of asymptomatic cigarette smokers, Respir. Med. 90 (8) (1996) 479-483.
23. S.P. Mahadik, D.R. Evans, Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications, Psychiatr. Clin. North Am. 26 (1) (2003) 85-102.